SQUAMOUS CELL CARCINOMA OF SKIN

This adverse event was reported 6044 times

These drugs are most commonly taken by patients reporting SQUAMOUS CELL CARCINOMA OF SKIN:

# Drug Count
0 LENALIDOMIDE 766
1 PREDNISONE 641
2 TACROLIMUS 587
3 TACROLIMUS EXTENDED-RELEASE CAPSULES 552
4 TACROLIMUS OINTMENT 0.1% 552
5 ADALIMUMAB 476
6 MYCOPHENOLATE MOFETIL 458
7 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 458
8 DEXAMETHASONE 421
9 DEXAMETHASONE 1.5 MG 421
See all common drugs associated with SQUAMOUS CELL CARCINOMA OF SKIN

SQUAMOUS CELL CARCINOMA OF SKIN is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 HYDROQUINONE 44 0.0743
1 BREXUCABTAGENE AUTOLEUCEL 75 0.0348
2 CASPOFUNGIN ACETATE 35 0.0221
3 ACITRETIN 58 0.0118
4 ERGOCALCIFEROL 345 0.0116
5 CEMIPLIMAB-RWLC 23 0.0110
6 VORICONAZOLE 336 0.0109
7 VEMURAFENIB 120 0.0100
8 AXICABTAGENE CILOLEUCEL 99 0.0097
9 SIROLIMUS 120 0.0088
See all drugs enriched for association with SQUAMOUS CELL CARCINOMA OF SKIN